Israel Active

Twenty-six leading healthcare professionals from 20 countries gathered in Haifa to participate in Rambam Medical Center’s Trauma Medicine Course.  The course included lectures, workshops and simulations, using Rambam’s vast experience of treating victims of war, terror and accidents.

Israel’s AV Medical Technologies completed a 30-patient evaluation of its Chameleon angioplasty balloon catheter, demonstrating clear advantages over standard balloon designs.  AV Medical plans to launch Chameleon in the USA soon. 

Israeli startup 2breathe Technologies has developed a sensor and smartphone app that helps users fall asleep and tracks their sleeping patterns. It plays musical tones in sync with an individual’s breathing pattern. The tones are gradually lengthened, and so users breathe slower and relax.

Israeli surgeons at Beilinson Hospital took out the kidney of a woman who had died of a stroke and transplanted it into her brother.  The kidney had been transplanted into the woman in an operation nine years previously.  It was the world’s fifth such operation and the first between relatives.

Israel’s Livia has developed a wearable device that provides instant relief from cramps, and lasts up to 15 hours on a single charge.  The device uses electrical pulses to block pain receptors.  Female journalists given a free Livia device have described it as “a life-changing technology”.

Israel’s Frutarom has developed Portusana®, an extract of the herb purslane.  Israeli scientists have confirmed its positive effects on blood sugar levels in adults with Type 2 Diabetes.  

Professor Nathan Karin of the Rappaport faculty of Medicine at Israel’s Technion Institute invented an antibody that activates cells in the immune system, thereby reducing inflammation. After years of development, Pfizer has now signed an agreement to commercialize the product.

Israel’s HIL Applied Medical develops safer focused proton beam lasers to treat tumors Now HIL has acquired US company Nanolabz which develops and builds smart nano-engineered targets and alignment systems for the short-pulse laser R&D sector.

Israel’s Chief Scientist has awarded NIS 5.6 million to Israel’s Collplant.  It will help finance projects, including the development of plant-based collagen and formulations intended for use as BioInk for 3D printing of tissues and organs.

International researchers and healthcare professionals attended a conference dubbed “State of the Heart.” at Haifa’s Rambam Hospital. It addressed global challenges in cardiovascular treatment and highlighted innovative changes in the field as a result of cutting-edge technology.